Potential Association of Doxycycline With the Onset of Primary Sclerosing Cholangitis: A Case Series

1Arizona College of Osteopathic Medicine, Midwestern University, Downers Grove, IL;

2Division of Hepatology, Mayo Clinic, Phoenix, AZ;

3Division of Gastroenterology and Hepatology, University of Missouri, Columbia, MO;

4Division of Gastroenterology, Department of Medicine, Olive View-UCLA Medical Center, Los Angeles, CA;

5National Patient Advocate Foundation, Arizona State University, Phoenix, AZ; and

6Division of Pediatric Gastroenterology, Hepatology and Nutrition, Stanford University, Palo Alto, CA.

*Address for correspondence: Professor of Medicine, Senior Advisor to the University Provost, Professor of Medicine, Office of the University Provost, College of Health Solutions, Arizona State University, 502 E. Monroe St, Phoenix, AZ 85004. E-mail: [email protected]

The authors have no conflicts of interest to declare.

K. D. Lindor, J. G. Buness, C. W. Buness, and A. H. Ali designed the study. A. H. Ali performed the statistics and calculations. K. D. Lindor, J. G. Buness, C. W. Buness, A. H. Ali, J. H. Tabibian, and K. L. Cox drafted and edited the manuscript. A. H. Ali created the table.

J. G. Buness and A. H. Ali are cofirst authors.

The Mayo Clinic IRB waived the requirement for IRB review of this study.

Patients were not required to provide informed consent to the study because the analysis used anonymous clinical data that were obtained from each patient after their agreement to participate in this study.

留言 (0)

沒有登入
gif